Iro, C.M. and Hamati, R. 2018. Pharmacogenetics of Major Depressive Disorder (MDD): Progress in Two Serotonergic Targets. University of Ottawa Journal of Medicine. 8, 2 (Nov. 2018), 35–39. DOI:https://doi.org/10.18192/uojm.v8i2.3858.